相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor
Elisabeth Perzborn et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Apixaban versus enoxaparin in patients with total knee arthroplasty A meta-analysis of randomised trials
Jiahao Huang et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Fibrate/Statin Initiation in Warfarin Users and Gastrointestinal Bleeding Risk
Hedi Schelleman et al.
AMERICAN JOURNAL OF MEDICINE (2010)
Cranberry Juice and Warfarin: When Bad Publicity Trumps Science
Jennifer Zikria et al.
AMERICAN JOURNAL OF MEDICINE (2010)
Hemorrhage During Warfarin Therapy Associated With Cotrimoxazole and Other Urinary Tract Anti-infective Agents A Population-Based Study
Hadas D. Fischer et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Effect of high-dose cranberry juice on the pharmacodynamics of warfarin in patients
Chadwick K. Mellen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor
Dagmar Kubitza et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Increased anticoagulant activity of warfarin used in combination with doxifluridine
Masaru Nakajima et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate An Open-Label, Parallel-Group, Single-Centre Study
Joachim Stangier et al.
CLINICAL PHARMACOKINETICS (2010)
In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies
Lifei Wang et al.
DRUG METABOLISM AND DISPOSITION (2010)
Drug interactions with antiretrovirals and warfarin
Michelle D. Liedtke et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Statin use and lipid levels in older adults: National Health and Nutrition Examination Survey, 2001 to 2006
Jennifer G. Robinson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2010)
Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers
Koichiro Ogata et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
New oral anticoagulants: a practical guide for clinicians
Ann K. Wittkowsky
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2010)
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
Michael Rud Lassen et al.
LANCET (2010)
Hyperprothrombinemia as a Result of a Possible Warfarin and Intravaginal Miconazole Interaction
Jeremy L. Thomas et al.
SOUTHERN MEDICAL JOURNAL (2010)
Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development
Mike Ufer
THROMBOSIS AND HAEMOSTASIS (2010)
Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: Comparison with direct inhibitors of factor VIIa, XIa and thrombin
Pancras C. Wong et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Coadministration of Dabigatran Etexilate and Atorvastatin Assessment of Potential Impact on Pharmacokinetics and Pharmacodynamics
Joachim Stangier et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2009)
Warfarin-Antiretroviral Interactions
Michelle D. Liedtke et al.
ANNALS OF PHARMACOTHERAPY (2009)
Prevalence of Use and the Risk of Adverse Effects Associated with Complementary and Alternative Medicine in a Cohort of Patients Receiving Warfarin
Vivian W. Y. Leung et al.
ANNALS OF PHARMACOTHERAPY (2009)
Probable Interaction Between Warfarin and Marijuana Smoking
Weeranuj Yamreudeewong et al.
ANNALS OF PHARMACOTHERAPY (2009)
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial
John H. Alexander et al.
CIRCULATION (2009)
Warfarin Interactions With Substances Listed in Drug Information Compendia and in the FDA-Approved Label for Warfarin Sodium
M. Anthony et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
Nirmala Raghavan et al.
DRUG METABOLISM AND DISPOSITION (2009)
The Absence of an Interaction Between Warfarin and Cranberry Juice: A Randomized, Double-Blind Trial
Jack Ansell et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Interaction Between Gemfibrozil and Warfarin: Case Report and Review of the Literature
Dave L. Dixon et al.
PHARMACOTHERAPY (2009)
Probable Warfarin Interaction with Menthol Cough Drops
Karen Coderre et al.
PHARMACOTHERAPY (2009)
Retrospective assessment of potential interaction between levofloxacin and warfarin
Gabriel Mercadal Orfila et al.
PHARMACY WORLD & SCIENCE (2009)
Intracerebral hemorrhage secondary to a warfarin-metronidazole interaction
Amanda Howard-Thompson et al.
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2008)
Elevated International Normalized Ratio after concurrent ingestion of cranberry sauce and warfarin
Kari A. Mergenhagen et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Interactions between warfarin and three commonly prescribed fluoroquinolones
Douglas N. Carroll et al.
ANNALS OF PHARMACOTHERAPY (2008)
Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects
M. I. Mohammed Abdul et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Drug interactions between warfarin and efavirenz or lopinavir-ritonavir in clinical treatment
Stefano Bonora et al.
CLINICAL INFECTIOUS DISEASES (2008)
Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects
Joachim Stangier et al.
CLINICAL PHARMACOKINETICS (2008)
Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate
Joachim Stangier
CLINICAL PHARMACOKINETICS (2008)
Warfarin With Fluoroquinolones, Sulfonamides, or Azole Antifungals: Interactions and the Risk of Hospitalization for Gastrointestinal Bleeding
H. Schelleman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Apixaban, an oral direct Factor Xa inhibitor: awaiting the verdict
Jennifer Carreiro et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment
Joachim Stangier et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Possible antiretroviral therapy-warfarin drug interaction
Patricia Pecora Fulco et al.
PHARMACOTHERAPY (2008)
Further evidence of a clinically significant levofloxacin-warfarin interaction
Jeffrey J. Glasheen et al.
SOUTHERN MEDICAL JOURNAL (2008)
The role of cytochrome P2C19 in R-warfarin pharmacokinetics and its interaction with omeprazole
Tsukasa Uno et al.
THERAPEUTIC DRUG MONITORING (2008)
The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans
Stefan Blech et al.
DRUG METABOLISM AND DISPOSITION (2008)
Impact of preemptive warfarin dose reduction on anticoagulation after initiation of trimethoprim-sulfamethoxazole or levofloxacin
Abrar Ahmed et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2008)
Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics
Carla Washington et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Potential interactions between complementary/alternative products and conventional medicines in a medicare population
Gary W. Elmer et al.
ANNALS OF PHARMACOTHERAPY (2007)
Interaction between lopinavir/ritonavir and warfarin
Christine A. Hughes et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
Interaction between warfarin and cranberry juice
Christine H. Paeng et al.
CLINICAL THERAPEUTICS (2007)
Bleeding complications with warfarin use - A prevalent adverse effect resulting in regulatory action
Diane K. Wysowski et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Probable warfarin-simvastatin interaction
Tone Westergren et al.
ANNALS OF PHARMACOTHERAPY (2007)
Interaction between warfarin and levofloxacin: Case series
Raja S. Vadlamudi et al.
SOUTHERN MEDICAL JOURNAL (2007)
Interaction of doxycycline and warfarin - An enhanced anticoagulant effect
Saiyid Akbar Hasan
CORNEA (2007)
Rivaroxaban (BAY 59-7939) - an oral, direct Factor Xa inhibitor - has no clinically relevant interaction with naproxen
Dagmar Kubitza et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Green tea may inhibit warfarin
Tsung O. Cheng
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Surveillance of prescription drug-related mortality using death certificate data
Diane K. Wysowski
DRUG SAFETY (2007)
The safety of levofloxacin in patients on warfarin
Jeffrey J. Glasheen et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Cranberry does not affect prothrombin time in male subjects on warfarin
Zhaoping Li et al.
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2006)
Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin
Scott Mathews et al.
PHARMACOTHERAPY (2006)
Indeterminable International Normalized Ratio with concurrent use of warfarin and gatifloxacin
Alan W. Y. Chock et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2006)
Potential interactions between prescription drugs and complementary and alternative medicines among patients in the emergency department
DM Taylor et al.
PHARMACOTHERAPY (2006)
Warfarin and its interactions with foods, herbs and other dietary supplements
Edith A. Nutescu et al.
EXPERT OPINION ON DRUG SAFETY (2006)
Effect of food, an antacid, and the H2 antagonist ranitidine on the absorption of BAY 59-7939 (Rivaroxaban), an oral, direct factor Xa inhibitor, in healthy subjects
D Kubitza et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Interaction of duloxetine and warfarin causing severe elevation of international normalized ratio
CJ Glueck et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Single-dose fluconazole for vulvovaginal candidiasis - Impact on prothrombin time in women taking warfarin
Mark A. Turrentine
OBSTETRICS AND GYNECOLOGY (2006)
Effect of oxolamine on anticoagulant effect of warfarin
KA Min et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2006)
Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: In vitro and clinical studies
DJ Greenblatt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Safety, tolerability, pharmacodynamics, and pharmacokinetics of rivaroxaban - an oral, direct Factor Xa inhibitor - Are not affected by aspirin
Dagmar Kubitza et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Antidepressants, warfarin, and the risk of hemorrhage
PA Kurdyak et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics
SG Simonson et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Moxifloxacin and warfarin: Additional evidence for a clinically relevant interaction
LM Arnold et al.
PHARMACOTHERAPY (2005)
Systematic overview of warfarin and its drug and food interactions
AM Holbrook et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement
J Stangier et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Possible warfarin interaction with menthol cough drops
PJ Kassebaum et al.
ANNALS OF PHARMACOTHERAPY (2005)
Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors
M Battistella et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Retrospective evaluation of a possible interaction between warfarin and levofloxacin
KL McCall et al.
PHARMACOTHERAPY (2005)
Oral anticoagulant drug interactions with statins: Case report of fluvastatin and review of the literature
MR Andrus
PHARMACOTHERAPY (2004)
Azithromycin and warfarin interaction
SP Shrader et al.
PHARMACOTHERAPY (2004)
Enhanced hypoprothrombinemia with warfarin due to azithromycin
KB Rao et al.
ANNALS OF PHARMACOTHERAPY (2004)
Miconazole oral gel and drug interactions
MN Pemberton et al.
BRITISH DENTAL JOURNAL (2004)
Drug point - Possible interaction between warfarin and cranberry juice
R Suvarna et al.
BRITISH MEDICAL JOURNAL (2003)
Voriconazole potentiates warfarin-induced prothrombin time prolongation
L Purkins et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo
GK Dresser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Interaction between warfarin and topical miconazole cream
A Devaraj et al.
BRITISH MEDICAL JOURNAL (2002)
Utilization of complementary and alternative medicine by United States adults - Results from the 1999 National Health Interview Survey
HY Ni et al.
MEDICAL CARE (2002)
Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors
D Williams et al.
CLINICAL PHARMACOKINETICS (2002)
Need for increased dose of warfarin in HIV patients taking nevirapine
D Dionisio et al.
AIDS (2001)
Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors
LL von Moltke et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Potentiation of warfarin's hypoprothrombinemic effect with miconazole vaginal suppositories
DJG Thirion et al.
PHARMACOTHERAPY (2000)
分享论文
